ArticleRSC advances2020

Strategic design to create HER2-targeting proteins with target-binding peptides immobilized on a fibronectin type III domain scaffold.

Wanaporn Yimchuen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.